Relyvrio, were on track for 10,000 patient level in the USA. They reached approx 1/3 of that.
The annual price was approx us$160,000 per patient.
Thats us$1.6b revenue annually.
Pharma industry colloquial description for a blockbuster, is greater than us$1b revenue. It was a throwaway line from Michael, trying to describe how big we could be without giving specifics, imho.
NZT gone but hasn't forgotten, page-43
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.005(2.70%) |
Mkt cap ! $71.26M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.0¢ | $371.5K | 2.007M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 339354 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 71619 | 5 |
View Market Depth
| Last trade - 13.53pm 20/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.0¢ |
Change
-0.005 ( 7.60 %) |
||||
| Open | High | Low | Volume | ||
| 18.5¢ | 19.0¢ | 18.0¢ | 639368 | ||
| Last updated 13.43pm 20/05/2024 ? | |||||
| PAA (ASX) Chart |